Shenzhen Yefeng Medical Biological Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Yefeng Medical Biological Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include YIPFUNG. The owner is based in Shenzhen.

Industrial Park,No.14,Jinhui Rd,Pingshan

502,Bldg 1,Biomedical Innovation

Shenzhen 518122 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

YIPFUNG
YIPFUNG
Registered 2024

Trademark Classifications

Shenzhen Yefeng Medical Biological Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen Yefeng Medical Biological Co., Ltd. have?

Shenzhen Yefeng Medical Biological Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Yefeng Medical Biological Co., Ltd. file in?

Shenzhen Yefeng Medical Biological Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhen Yefeng Medical Biological Co., Ltd.'s most well-known trademarks?

Shenzhen Yefeng Medical Biological Co., Ltd.'s registered trademark portfolio includes well-known marks such as YIPFUNG. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Yefeng Medical Biological Co., Ltd.'s trademark registration success rate?

Shenzhen Yefeng Medical Biological Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.